tranexamic acid has been researched along with Deficiency, Factor 5 in 4 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jain, S | 1 |
| Acharya, SS | 1 |
| Hayward, CPM | 1 |
| Tasneem, S | 1 |
| Rivard, GE | 2 |
| Passarelli, PC | 1 |
| De Angelis, P | 1 |
| Pasquantonio, G | 1 |
| Manicone, PF | 1 |
| Verdugo, F | 1 |
| D'Addona, A | 1 |
| Blavignac, J | 1 |
| Bunimov, N | 1 |
| Hayward, CP | 1 |
2 reviews available for tranexamic acid and Deficiency, Factor 5
| Article | Year |
|---|---|
Inherited disorders of the fibrinolytic pathway.
Topics: alpha-2-Antiplasmin; Antifibrinolytic Agents; Blood Platelets; Factor V Deficiency; Fibrinolysis; He | 2019 |
Quebec platelet disorder: update on pathogenesis, diagnosis, and treatment.
Topics: Antifibrinolytic Agents; Factor V Deficiency; Gene Duplication; Genetic Predisposition to Disease; H | 2011 |
2 other studies available for tranexamic acid and Deficiency, Factor 5
| Article | Year |
|---|---|
Improved platelet counts during prolonged tranexamic therapy for Quebec platelet disorder implicate the underlying fibrinolytic defect as the cause of lower platelet counts.
Topics: Antifibrinolytic Agents; Blood Coagulation Disorders; Blood Platelets; Factor V Deficiency; Fibrinol | 2020 |
Management of Single Uncomplicated Dental Extractions and Postoperative Bleeding Evaluation in Patients With Factor V Deficiency: A Local Antihemorrhagic Approach.
Topics: Adult; Aged; Antifibrinolytic Agents; Factor V Deficiency; Female; Gelatin Sponge, Absorbable; Hemos | 2018 |